207 related articles for article (PubMed ID: 7504086)
1. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain.
Liptrot J; Holdup D; Phillipson O
J Neurochem; 1993 Dec; 61(6):2199-206. PubMed ID: 7504086
[TBL] [Abstract][Full Text] [Related]
2. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.
Liptrot J; Holdup D; Phillipson O
J Neural Transm Gen Sect; 1994; 96(1):51-62. PubMed ID: 7857591
[TBL] [Abstract][Full Text] [Related]
3. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
Clement HW; Grote C; Wesemann W
J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
[No Abstract] [Full Text] [Related]
4. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
5. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain.
Kamata M; Higuchi H; Yoshimoto M; Yoshida K; Shimizu T
Eur Neuropsychopharmacol; 2000 Mar; 10(2):129-32. PubMed ID: 10706995
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
7. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
Knoll J; Miklya I
Arch Int Pharmacodyn Ther; 1994; 328(1):1-15. PubMed ID: 7893186
[TBL] [Abstract][Full Text] [Related]
8. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
[TBL] [Abstract][Full Text] [Related]
9. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
Luthman J; Brodin E; Sundström E; Wiehager B
Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172
[TBL] [Abstract][Full Text] [Related]
10. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Sivam SP
Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
[TBL] [Abstract][Full Text] [Related]
12. Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Halladay AK; Kirschner E; Hesse K; Fisher H; Wagner GC
Pharmacol Toxicol; 2001 Nov; 89(5):237-48. PubMed ID: 11881977
[TBL] [Abstract][Full Text] [Related]
13. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
Castaño A; Herrera AJ; Cano J; Machado A
Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
[TBL] [Abstract][Full Text] [Related]
14. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
16. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection.
Saligaut C; Chretien P; Daoust M; Moore N; Boismare F
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539
[TBL] [Abstract][Full Text] [Related]
17. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
[TBL] [Abstract][Full Text] [Related]
18. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
19. Effect of neutron-gamma radiation on dopamine and serotonin metabolism in the rat brain: a regional analysis.
Foulon O; Lalouette F; Lambert F; Martin S; Fatôme M; Martin C
J Neurosci Res; 1999 Mar; 55(6):770-5. PubMed ID: 10220117
[TBL] [Abstract][Full Text] [Related]
20. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
Lategan AJ; Marien MR; Colpaert FC
Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
